Risk factors for progression from smoldering into active myeloma: additional insights from a population-based study
Eur J Haematol
.
2016 Sep;97(3):217-8.
doi: 10.1111/ejh.12750.
Author
Jorge J Castillo
1
Affiliation
1
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
PMID:
26918423
DOI:
10.1111/ejh.12750
No abstract available
Publication types
Editorial
MeSH terms
Disease Progression
Humans
Multiple Myeloma / epidemiology
Multiple Myeloma / etiology*
Multiple Myeloma / pathology*
Paraproteinemias / epidemiology
Paraproteinemias / pathology*
Population Surveillance
Risk Factors